CIK 0001862150 · <br>Emerging growth company
Cingulate Inc.
Sign in to watch- Ticker
- CING
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 863825535
- Phone
- (913) 942-2300
- Business address
- 1901 W. 47TH PLACE, KANSAS CITY, KS, 66205
- Former names
- Cingulate Inc.
Securities
- CING Common Stock Nasdaq
- CINGW Warrants Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-30 | Silva Raul R. EVP and CSO | Grant or award · Stock Option (right to Buy) | +4,293 | 4,293 | ||
| 2026-07-16 | Schaffer Shane J. Chief Executive Officer | Grant or award · Stock Option (right to Buy) | +197,650 | 197,650 | ||
| 2026-07-16 | Schaffer Shane J. Chief Executive Officer | Grant or award · Stock Option (right to Buy) | +97,350 | 97,350 | ||
| 2026-07-16 | Downey Bryan Wade EVP & Chief Commercial Officer | Grant or award · Stock Option (right to Buy) | +67,000 | 67,000 | ||
| 2026-07-16 | Downey Bryan Wade EVP & Chief Commercial Officer | Grant or award · Stock Option (right to Buy) | +33,000 | 33,000 | ||
| 2026-07-16 | Lawrence Bryan Jay Director | Grant or award · Stock Option (right to Buy) | +20,000 | 20,000 | ||
| 2026-07-16 | Brams Matthew EVP and Chief Medical Officer | Grant or award · Stock Option (right to Buy) | +53,600 | 53,600 | ||
| 2026-07-16 | Brams Matthew EVP and Chief Medical Officer | Grant or award · Stock Option (right to Buy) | +26,400 | 26,400 | ||
| 2026-07-16 | Hargroves Thomas Jeffrey Director | Grant or award · Stock Option (right to Buy) | +20,000 | 20,000 | ||
| 2026-07-16 | Callahan Jennifer L. EVP and CFO | Grant or award · Stock Option (right to Buy) | +40,200 | 40,200 | ||
| 2026-07-16 | Callahan Jennifer L. EVP and CFO | Grant or award · Stock Option (right to Buy) | +19,800 | 19,800 | ||
| 2026-07-16 | Werth Peter J. Director | Grant or award · Stock Option (right to Buy) | +20,000 | 20,000 | ||
| 2026-07-16 | Silva Raul R. EVP and CSO | Grant or award · Stock Option (right to Buy) | +53,600 | 53,600 | ||
| 2026-07-16 | Silva Raul R. EVP and CSO | Grant or award · Stock Option (right to Buy) | +26,400 | 26,400 | ||
| 2026-06-30 | Silva Raul R. EVP and CSO | Grant or award · Stock Option (right to Buy) | +3,885 | 3,885 | ||
| 2026-03-31 | Silva Raul R. EVP and CSO | Grant or award · Stock Option (right to Buy) | +3,422 | 3.42 | ||
| 2026-03-09 | Hargroves Thomas Jeffrey Director | Grant or award · Stock Option (right to Buy) | +15,000 | 15,000 | ||
| 2026-03-09 | Silva Raul R. EVP and CSO | Grant or award | +4,526 | 6,473 | ||
| 2026-03-09 | Silva Raul R. EVP and CSO | Shares withheld for taxes | −1,828 | 4,645 | ||
| 2026-03-09 | Schaffer Shane J. Chief Executive Officer | Grant or award | +6,862 | 7,035 |
Page 1 of 11 · 202 trades